M. Wszolek

发表

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy.

R. Millikan, S. Groshen, B. Czerniak, 2014, The Journal of urology.

Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification.

M. Blute, Chin-Lee Wu, A. Mojtahed, 2021, Urologic oncology.

Comparison of hilar clamping and non‐hilar clamping partial nephrectomy for tumours involving a solitary kidney

J. Libertino, P. Kenney, M. Wszolek, 2011, BJU international.

Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy.

John W. Davis, C. Pettaway, L. Pisters, 2016, The Canadian journal of urology.

Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series.

A. Zietman, Chin-Lee Wu, Dimitar V Zlatev, 2022, Human pathology.

Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.

A. Niemierko, M. Michaelson, A. Zietman, 2017, European urology.

Concordance of systematic and fusion biopsy with surgical pathology.

M. Harisinghani, M. Blute, Chin-Lee Wu, 2019, Journal of Clinical Oncology.

Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles

Joshua M. Shulman, J. Shulman, M. Feany, 2001, Science.

The p63 Protein Isoform ΔNp63α Inhibits Epithelial-Mesenchymal Transition in Human Bladder Cancer Cells

B. Czerniak, C. Dinney, D. McConkey, 2012, The Journal of Biological Chemistry.

PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53

C. Benes, J. Efstathiou, D. Citrin, 2018, Oncogene.

Plasma microRNA profiles for bladder cancer detection.

Wang Jing, Alexander Zien, Lixia Diao, 2013, Urologic oncology.

Identification of tumor and invasion suppressor gene modulators in bladder cancer by different classes of histone deacetylase inhibitors using reverse phase protein arrays.

D. Canes, K. Rieger-Christ, I. Summerhayes, 2010, The Journal of urology.

Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy.

A. Niemierko, M. Blute, A. Zietman, 2017, European urology.

Surgical management of large renal tumors

J. Libertino, C. Wotkowicz, M. Wszolek, 2008, Nature Clinical Practice Urology.

Resection of renal tumors invading the vena cava.

J. Libertino, C. Wotkowicz, M. Wszolek, 2008, The Urologic clinics of North America.

Novel ZEB1 expression in bladder tumorigenesis

M. Loda, K. Rieger-Christ, I. Summerhayes, 2011, BJU international.

Laparoscopy for the detection and treatment of early complications from minimally invasive urologic surgery.

A. Moinzadeh, D. Canes, A. Sorcini, 2014, Journal of endourology.

Open Partial Nephrectomy

J. Libertino, P. Kenney, M. Wszolek, 2013 .

TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer

B. Broom, B. Czerniak, C. Dinney, 2020, Molecular Cancer Research.

Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis

B. Czerniak, C. Dinney, D. McConkey, 2016, Oncotarget.

MULTIPARAMETRIC MRI/ULTRASOUND FUSION BIOPSY IMPROVES BUT DOES NOT REPLACE STANDARD TEMPLATE BIOPSY FOR THE DETECTION OF PROSTATE CANCER.

M. Harisinghani, M. Blute, K. Salari, 2019, The Journal of urology.

Nonclamping partial nephrectomy: towards improved nephron sparing

J. Libertino, P. Kenney, M. Wszolek, 2011, Nature Reviews Urology.

Bladder cancer: Quality of life in patients with non-muscle-invasive bladder cancer

Alejandro Sanchez, M. Wszolek, 2015, Nature Reviews Urology.

A MicroRNA expression profile defining the invasive bladder tumor phenotype.

K. Rieger-Christ, I. Summerhayes, J. Libertino, 2011, Urologic oncology.

Multi-institutional matched comparison of radical cystectomy to trimodality therapy for muscle-invasive bladder cancer.

A. Niemierko, R. Bristow, A. Zietman, 2022, Journal of Clinical Oncology.

Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer

A. Niemierko, A. Zietman, J. Efstathiou, 2018, The Journal of urology.

Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer.

C. Dinney, W. Benedict, B. Hutchins, 2013, The Journal of urology.

Complications and Outcomes of Salvage Cystectomy after Trimodality Therapy

M. Blute, J. Efstathiou, W. Shipley, 2021, The Journal of urology.

Face, content, and construct validity of dV-trainer, a novel virtual reality simulator for robotic surgery.

A. Moinzadeh, Matthew F. Wszolek, J. Libertino, 2009, Urology.

A novel approach to using matrix metalloproteinases for bladder cancer.

K. Loughlin, I. Summerhayes, J. Libertino, 2009, The Journal of urology.

Healthcare Resource Utilization After Surgical Treatment of Cancer: Value of Minimally Invasive Surgery

R. Goldstone, T. Francone, R. Ricciardi, 2022, Surgical Endoscopy.

M. Vangel, S. Razdan, S. Razdan, 2022, Surgery.

Open Partial Nephrectomy

Marianne M. Casilla-Lennon, J. Libertino, P. Kenney, 2019, Renal Cancer.

Does knowing the risk of relapse in localized renal cell carcinoma matter?

M. Wszolek, 2019, BJU international.

An Unusual Case of a Scrotal Porocarcinoma and Review of the Literature

K. Cornejo, M. Wszolek, Jakob M. T. Moran, 2022, The American Journal of dermatopathology.

Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer.

C. Dinney, B. Hutchins, A. Kamat, 2013, The Journal of urology.

A MICRORNA EXPRESSION PROFILE INVOLVED IN THE INVASIVE BLADDER TUMOR PHENOTYPE

K. Rieger-Christ, I. Summerhayes, J. Libertino, 2009 .